Home › Small Cell Lung Cancer › Washington › Seattle

Pag-aaral pangklinika para sa Small Cell Lung Cancer sa Seattle, WA

Isang pag-aaral para sa Small Cell Lung Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Seattle. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Nagre-recruitPhase 1/2

University of Washington, Fred Hutchinson Cancer Center, Seattle

Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04585750

Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors

Nagre-recruitPhase 1

Fred Hutchinson Cancer Research Center, Seattle

Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07006727

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Nagre-recruitPhase 1

University of Washington Fred Hutchinson, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05983432

A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy

Nagre-recruitPhase 1/2

Fred Hutchinson Cancer Center, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07564401

A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

Nagre-recruitPhase 3

Swedish Medical Center, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06646276

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Nagre-recruitPhase 1/2

Avenzo Therapeutics Recruiting Site, Seattle

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07038343

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors

Nagre-recruitPhase 1/2

Fred Hutch Cancer Research, Seattle

Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT06726148

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

Nagre-recruitPhase 1/2

Fred Hutch Cancer Center, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 15, 2026 · NCT05652686

A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer

Nagre-recruitPhase 1/2

Swedish Cancer Institute, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 9, 2026 · NCT07174583

Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)

Nagre-recruitPhase 1

Swedish Cancer Institute, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 26, 2026 · NCT06598306

Pag-aaral para sa Small Cell Lung Cancer sa ibang lungsod

Iba pang pag-aaral sa Seattle

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.